Overall Survival of CDK4/6-Inhibitor–Based Treatments in Clinically Relevant Subgroups of Metastatic Breast Cancer: Systematic Review and Meta-AnalysisFrancesco Schettini, Daniele Generali, Grazia Arpino et al.|JNCI Journal of the National Cancer Institute|2020Cited by 102
The evolving landscape of hormone receptor-positive/HER2-negative metastatic breast cancer (EVOLVE): An Italian Delphi consensus reportFederica Miglietta, Grazia Arpino, Maria Grazia Razeti et al.|Critical Reviews in Oncology/Hematology|2025Cited by 4